Durata Therapeutics Inc (DRTX) financial statements (2021 and earlier)

Company profile

Business Address 200 SOUTH WACKER DRIVE
CHICAGO, IL 60606
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments35354260678347
Cash and cash equivalents28212137446133
Short-term investments8142123222214
Receivables0      
Inventory, net of allowances, customer advances and progress billings3  
Inventory3      
Prepaid expense   1   
Prepaid expense and other current assets4
Income taxes receivable2   
Deferred tax assets   0   
Other undisclosed current assets674132 
Total current assets:44424563708551
Noncurrent Assets
Property, plant and equipment2111111
Intangible assets, net (including goodwill)21212121212121
Goodwill6666666
Intangible assets, net (excluding goodwill)15151515151515
Restricted cash and investments2211111
Deferred costs   0   
Other noncurrent assets444411 
Prepaid expense and other noncurrent assets1
Other undisclosed noncurrent assets10101010111111
Total noncurrent assets:38383737353535
TOTAL ASSETS:82798210010512086
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2010131691416
Accounts payable124353511
Accrued liabilities8697694
Employee-related liabilities   2   
Taxes payable0 120 0
Debt210 31 
Other undisclosed current liabilities11  (2)   
Total current liabilities:33111314121516
Noncurrent Liabilities
Long-term debt and lease obligation64392525161718
Long-term debt, excluding current maturities64392525161718
Liabilities, other than long-term debt2222211
Accounts payable and accrued liabilities1      
Accrued income taxes111111
Other liabilities10000  
Other undisclosed noncurrent liabilities 252421222222
Total noncurrent liabilities:66665048404141
Total liabilities:98776362515657
Stockholders' equity
Stockholders' equity attributable to parent, including:(16)31939536529
Common stock0000000
Additional paid in capital211210209208207206152
Accumulated deficit(227)      
Other undisclosed stockholders' equity attributable to parent (207)(189)(169)(154)(142)(123)
Total stockholders' equity:(16)31939536529
TOTAL LIABILITIES AND EQUITY:82798210010512086

Income statement (P&L) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Gross profit:10      
Operating expenses(45)(19)(19)(13)(11)(18)(15)
Other operating income (expense), net(2)(1)(1)(3)(1)(1)0
Other undisclosed operating income181131131
Operating income (loss):(18)(19)(19)(13)(11)(18)15
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)0     
Interest and debt expense(2)     (0)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (2)   
Income (loss) from continuing operations before equity method investments, income taxes:(20)(19)(19)(14)(11)(18)15
Other undisclosed income (loss) from continuing operations before income taxes0(1)(1)(1)(1)(1)0
Income (loss) from continuing operations before income taxes:(20)(20)(20)(15)(12)(19)16
Income tax expense (benefit)(0)2(0)(1)(0)(0)(0)
Income (loss) before gain (loss) on sale of properties:(20)(18)(20)(16)(12)(19)15
Other undisclosed net loss      (31)
Net loss available to common stockholders, diluted:(20)(18)(20)(16)(12)(19)(16)

Comprehensive Income ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net loss:(20)(18)(20)(16)(12)(19)(16)
Comprehensive loss, net of tax, attributable to parent:(20)(18)(20)(16)(12)(19)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: